Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving hydrolase
Patent
1995-05-25
2000-05-02
Wax, Robert A.
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving hydrolase
435 24, 435212, 435219, 435226, C12Q 137
Patent
active
060571195
ABSTRACT:
Interleukin-1.beta. converting enzyme ("ICE") processes an inactive precursor to the pro-inflammatory cytokine, interleukin-1.beta.. The high-resolution structure of human ICE crystallized in complex with an inhibitor is determined by X-ray diffraction. The active site spans both the 10 and 20 kilodalton subunits. The accessory binding site is composed of residues from the p10 and p20 subunits that are adjacent to the two-fold axis of the crystal. The structure coordinates of the enzyme may be used to design novel classes of ICE inhibitors.
REFERENCES:
patent: 5492824 (1996-02-01), Talanian et al.
Bryan, P.N., "Protein Engineering", Biotech Adv., 5, pp. 221-234 (1987).
Campbell, I.D. and Dwek, R.A., "Diffraction", Biol. Spect., Ch. 12, pp. 299-327 (1984).
Kajihara, A., et al., "Protein Modeling Using a Chimera Reference Protein Derived From Exons", Protein Engineering, 6, pp. 615-620 (1993).
Musil, D., et al., "The Refined 2.15 .ANG. X-Ray Crystal Structure of Human Liver Cathepsin B: The Structural Basis for its Specificity", EMBO J., 10, pp. 2321-2330 (1991).
Russell, A.J. and Fersht, A.R., "Rational Modification of Enzyme Catalysis by Engineering Surface Charge", Nature, 328, pp. 496-500 (1987).
Walker, N.P.C. et al., "Crystal Structure of the Cysteine Protease Interleukin-1.beta.-Converting Enzyme: A (p20/p10).sub.2 Homodimer", Cell., 78, pp. 343-352 (Jul., 1994).
Wilson, K.P., et al., "Structure and Mechanism of Interleukin-1.beta. Convertig Enzyme", Nature, 370, pp. 270-275 (Jul., 1994).
Wright, C.S. et al., "Structure of Subtilisn BPN' at 2.5 .ANG. Resolution", Nature, 221, pp. 235-242 (1969).
Sielecki, A.R. et al., "Structure of Recombinant Human Renin, a Target for Cardiovascular-Active Drugs, at 2.5 .ANG. Resolution", Science, 243, pp. 1346-1351 (1989).
Thompson, J.A., et al., "In Vitro Folding and Autoprocessing of Active Interleukin-1.beta. Converting Enzyme From an Inactive Recombinant Precursor", J. Cell. Biochem. Keystone Symp. on Molec. & Cell. Biol., Supp. 18 D, p. 148, S 229 (Mar., 1994).
Griffith James P.
Kim Eunice E.
Livingston David J.
Wilson Keith P.
Dixon Lisa A.
Haley, Jr. Esq. James F.
Nashed Nashaat T.
Vertex Pharmaceuticals Incorporated
Wax Robert A.
LandOfFree
Crystal structure and mutants of interleukin-1.beta. converting does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Crystal structure and mutants of interleukin-1.beta. converting , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Crystal structure and mutants of interleukin-1.beta. converting will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1592772